NeuroPace Inc

NeuroPace Inc (NPCE) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the near term. However, absence of recent events does not indicate absence of risk—the company's financing structure, shareholder dilution trends, and longer-term regulatory exposure warrant deeper analysis. Our full $49 Report extends the lookback to 12 months, calculates dilution risk scores across cap table changes, contextualizes any 8-K filings within management tenure and sector patterns, and flags AI-adjacent regulatory signals relevant to medical device companies. The full $49 Report adds comprehensive dilution analysis, 12-month event history, and forward-risk scoring across financing and compliance vectors.